广发纳斯达克生物科技C美元(016471)
动态评分： 5.63分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | GILD | 吉利德科学 | 1302.95 | 7.5% |
| 2024-12-31 | AMGN | 安进 | 1203.22 | 6.93% |
| 2024-12-31 | REGN | 再生元制药 | 1161.84 | 6.69% |
| 2024-12-31 | VRTX | 福泰制药 | 1123.46 | 6.47% |
| 2024-12-31 | AZN | 阿斯利康(US ADR) | 575.87 | 3.31% |
| 2024-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 458.06 | 2.64% |
| 2024-12-31 | BIIB | 生化基因 | 336.37 | 1.94% |
| 2024-12-31 | ILMN | Illumina Inc | 319.88 | 1.84% |
| 2024-12-31 | ARGX | argenx SE ADR | 299.29 | 1.72% |
| 2024-12-31 | MRNA | Moderna Inc | 241.51 | 1.39% |
| 2024-12-31 | UTHR | 联合治疗 | 237.66 | 1.37% |
| 2024-12-31 | VTRS | Viatris Inc | 224.29 | 1.29% |
| 2024-12-31 | SNY | 赛诺菲 | 219.18 | 1.26% |
| 2024-12-31 | NBIX | 神经分泌生物科学 | 208.61 | 1.2% |
| 2024-12-31 | INCY | 因塞特医疗 | 200.84 | 1.16% |
| 2024-12-31 | SMMT | Summit Therapeutics Inc | 198.62 | 1.14% |
| 2024-12-31 | BMRN | 拜玛林制药 | 189.09 | 1.09% |
| 2024-12-31 | INSM | Insmed Inc | 186.41 | 1.07% |
| 2024-12-31 | SRPT | Sarepta Therapeutics Inc | 175.33 | 1.01% |
| 2024-12-31 | RPRX | Royalty Pharma plc-A | 171.07 | 0.98% |
公告&资料